![Defending AI, Machine Learning Patents in Life Sciences](https://www.mintz.com/sites/default/files/styles/homepage_banner/public/media/images/2024-10-02/Homepage_Hero_Defending%20AI_1002.jpg?itok=HHH_qOkg)
Defending AI, Machine Learning Patents in Life Sciences
Defending AI, Machine Learning Patents in Life Sciences
Even a decade after the US Supreme Court’s decision in Alice v. CLS Bank, patents continue to be invalidated under its two-part test for patent eligibility. Intellectual Property Chair Michael Renaud and Associates Meena Seralathan, Simone Yhap, and Williams Dixon, explore this evolving landscape in a recent Law360 article. The attorneys focus on the implications for artificial intelligence and machine learning patents in the life sciences sector and share insights into navigating common pitfalls that have recently derailed AI/ML patents.
Learn MoreAwards and Recognition
More from Mintz
Our Offices
-
Boston
t / 617.542.6000 -
Los Angeles
t / 310.586.3200 -
Miami
t / 786.949.6600 -
New York
t / 212.935.3000 -
San Diego
t / 858.314.1500 -
San Francisco
t / 415.432.6000 -
Toronto
t / 647.499.2828 -
Washington, DC
t / 202.434.7300